These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34771590)

  • 1. N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.
    Kyr M; Svobodnik A; Stepanova R; Hejnova R
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
    Barry E; Walsh JA; Weinrich SL; Beaupre D; Blasi E; Arenson DR; Jacobs IA
    Paediatr Drugs; 2021 Jul; 23(4):381-394. PubMed ID: 34173206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety interventions for the prevention of accidents at work: A systematic review.
    Dyreborg J; Lipscomb HJ; Nielsen K; Törner M; Rasmussen K; Frydendall KB; Bay H; Gensby U; Bengtsen E; Guldenmund F; Kines P
    Campbell Syst Rev; 2022 Jun; 18(2):e1234. PubMed ID: 36911341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Designs to Optimize Treatments for Individuals: Personalized N-of-1 Trials.
    Davidson KW; Silverstein M; Cheung K; Paluch RA; Epstein LH
    JAMA Pediatr; 2021 Apr; 175(4):404-409. PubMed ID: 33587109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
    Yin J; Shen S; Shi Q
    Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining patterns of traditional Chinese medicine use in pediatric oncology: A systematic review, meta-analysis and data-mining study.
    Lam CS; Peng LW; Yang LS; Chou HWJ; Li CK; Zuo Z; Koon HK; Cheung YT
    J Integr Med; 2022 Sep; 20(5):402-415. PubMed ID: 35750623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric oncology drug development and dosage optimization.
    Cheung SYA; Hay JL; Lin YW; de Greef R; Bullock J
    Front Oncol; 2023; 13():1235947. PubMed ID: 38348118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols.
    Khan T; Stewart M; Blackman S; Rousseau R; Donoghue M; Cohen K; Seibel N; Fleury M; Benettaib B; Malik R; Vassal G; Reaman G
    Ther Innov Regul Sci; 2019 Mar; 53(2):270-278. PubMed ID: 29759018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial designs for testing biomarker-based personalized therapies.
    Lai TL; Lavori PW; Shih MC; Sikic BI
    Clin Trials; 2012 Apr; 9(2):141-54. PubMed ID: 22397801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugs.
    Zettler ME
    Expert Rev Anticancer Ther; 2022 Mar; 22(3):317-321. PubMed ID: 35051348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Alteration-Driven Clinical Trial Designs in Oncology.
    Simon R
    Ann Intern Med; 2016 Aug; 165(4):270-8. PubMed ID: 27214515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.